164 related articles for article (PubMed ID: 28739871)
1. Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity.
Zeng Y; Stauffer S; Zhou J; Chen X; Chen Y; Dong J
J Biol Chem; 2017 Sep; 292(36):15028-15038. PubMed ID: 28739871
[TBL] [Abstract][Full Text] [Related]
2. CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity.
Zhang L; Chen X; Stauffer S; Yang S; Chen Y; Dong J
Oncotarget; 2015 Oct; 6(31):31399-412. PubMed ID: 26375055
[TBL] [Abstract][Full Text] [Related]
3. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis.
Chen X; Stauffer S; Chen Y; Dong J
J Biol Chem; 2016 Jul; 291(28):14761-72. PubMed ID: 27226586
[TBL] [Abstract][Full Text] [Related]
4. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer.
Jiao S; Wang H; Shi Z; Dong A; Zhang W; Song X; He F; Wang Y; Zhang Z; Wang W; Wang X; Guo T; Li P; Zhao Y; Ji H; Zhang L; Zhou Z
Cancer Cell; 2014 Feb; 25(2):166-80. PubMed ID: 24525233
[TBL] [Abstract][Full Text] [Related]
5. MST2 phosphorylation at serine 385 in mitosis inhibits its tumor suppressing activity.
Chen X; Chen Y; Dong J
Cell Signal; 2016 Dec; 28(12):1826-1832. PubMed ID: 27566175
[TBL] [Abstract][Full Text] [Related]
6. YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP.
Cai J; Choi K; Li H; Pulgar Prieto KD; Zheng Y; Pan D
Genes Dev; 2022 Nov-Dec 1; 36(21-24):1119-1128. PubMed ID: 36522128
[TBL] [Abstract][Full Text] [Related]
7. VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.
Deng X; Fang L
Am J Cancer Res; 2018; 8(6):932-943. PubMed ID: 30034932
[TBL] [Abstract][Full Text] [Related]
8. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.
Yang S; Zhang L; Liu M; Chong R; Ding SJ; Chen Y; Dong J
Cancer Res; 2013 Nov; 73(22):6722-33. PubMed ID: 24101154
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
[TBL] [Abstract][Full Text] [Related]
10. CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.
Stauffer S; Zeng Y; Zhou J; Chen X; Chen Y; Dong J
Cell Signal; 2017 Nov; 39():74-83. PubMed ID: 28780319
[TBL] [Abstract][Full Text] [Related]
11. LIMD1 phosphorylation in mitosis is required for mitotic progression and its tumor-suppressing activity.
Zhou J; Zhang L; Zhou W; Chen Y; Cheng Y; Dong J
FEBS J; 2019 Mar; 286(5):963-974. PubMed ID: 30600590
[TBL] [Abstract][Full Text] [Related]
12. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.
Zhang W; Gao Y; Li P; Shi Z; Guo T; Li F; Han X; Feng Y; Zheng C; Wang Z; Li F; Chen H; Zhou Z; Zhang L; Ji H
Cell Res; 2014 Mar; 24(3):331-43. PubMed ID: 24458094
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.
Feng X; Lu T; Li J; Yang R; Hu L; Ye Y; Mao F; He L; Xu J; Wang Z; Liu Y; Zhang Y; Ji H; Zhao Y; Cheng S; Tian W; Zhang L
Hepatology; 2020 Jun; 71(6):1988-2004. PubMed ID: 31538665
[TBL] [Abstract][Full Text] [Related]
14. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.
Zhang W; Xu J; Li J; Guo T; Jiang D; Feng X; Ma X; He L; Wu W; Yin M; Ge L; Wang Z; Ho MS; Zhao Y; Fei Z; Zhang L
J Biol Chem; 2018 Nov; 293(44):17119-17134. PubMed ID: 30209132
[TBL] [Abstract][Full Text] [Related]
15. VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Liao G; Xu W; Zhang S
Med Oncol; 2015 Mar; 32(3):83. PubMed ID: 25701461
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 11 (USP11) functions as a tumor suppressor through deubiquitinating and stabilizing VGLL4 protein.
Zhang E; Shen B; Mu X; Qin Y; Zhang F; Liu Y; Xiao J; Zhang P; Wang C; Tan M; Fan Y
Am J Cancer Res; 2016; 6(12):2901-2909. PubMed ID: 28042509
[TBL] [Abstract][Full Text] [Related]
17. Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.
Gao J; Zhang Y; Chen H; Chen Q; Feng D; Zhang L; Li C
J Biomol Struct Dyn; 2019 Jul; 37(10):2538-2545. PubMed ID: 30051771
[TBL] [Abstract][Full Text] [Related]
18. VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
Xu K; Zhao H; Qiu X; Liu X; Zhao F; Zhao Y
Mediators Inflamm; 2020; 2020():8292173. PubMed ID: 33456372
[TBL] [Abstract][Full Text] [Related]
19. Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion.
Wu A; Wu Q; Deng Y; Liu Y; Lu J; Liu L; Li X; Liao C; Zhao B; Song H
EMBO J; 2019 Jan; 38(1):. PubMed ID: 30396996
[TBL] [Abstract][Full Text] [Related]
20. VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer.
Jiao S; Li C; Hao Q; Miao H; Zhang L; Li L; Zhou Z
Nat Commun; 2017 Jan; 8():14058. PubMed ID: 28051067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
